Skip to main content Deutsch

Further Information

Sorry, this content is only available in German!

Our aims

B lymphocytes are immune cells that produce antibodies and provide long-lasting immunity. Although B cells are a major emerging therapeutic target in cancer and autoimmune rheumatological conditions, there are still substantial gaps in understanding how B cells can be harnessed to treat cardiovascular disease (CVD).

 

 

 

This project is a Transatlantic Network sponsored by the Leducq Foundation for Cardiovascular Disease